Nansi López-Valverde1,2
Antonio López-Valverde1,2
Bruno Macedo de Sousa3Cinthia Rodríguez4
Ana Suárez5*
Juan Manuel Aragoneses6- 1Department of Surgery, University of Salamanca, Salamanca, Spain
- 2Instituto de Investigación Biomédica de Salamanca (IBSAL), Salamanca, Spain
- 3Institute for Occlusion and Orofacial Pain Faculty of Medicine, University of Coimbra, Coimbra, Portugal
- 4Department of Dentistry, Universidad Federico Henríquez y Carvajal, Santo Domingo, Dominican Republic
- 5Department of Preclinical Dentistry, School of Biomedical Sciences, Universidad Europea de Madrid, Madrid, Spain
- 6Faculty of Dentistry, Universidad Alfonso X El Sabio, Madrid, Spain
Halitosis or oral malodor is a condition caused by the putrefaction of sulfur-containing amino acids. It affects 30–50% of the population and causes social rejection, reducing quality of life, and self-esteem. Probiotics, especially Lactobacillus species, have been proposed for the treatment of genuine halitosis, due to their ability to reduce bacterial colonization. Our objective was to evaluate their use for the treatment of oral halitosis. Applying the PRISMA statement guidelines, we searched PubMed, EMBASE, and Web of Science databases for scientific articles from the last 15 years, up to July 2021. The keywords used were “Probiotics”; “Halitosis”; “Mouth diseases”; “Oral health”; “Humans”; “Randomized Clinical Trials” according to the question, “Are probiotics effective for the reduction or elimination of oral halitosis?” Fourteen studies were identified, although only four met the inclusion criteria. We evaluated 283 participants treated with two different probiotics, with a follow-up of at least 2 weeks. Risk of bias was assessed using the Cochrane Collaboration tool. A fixed-effects meta-analysis was performed. No statistical significance was found (p = 0.53). Despite the limitations of this meta-analysis, we believe that some probiotics have a beneficial effect on halitosis, although more clinical trials are needed to establish real evidence on this aspect.
Systematic Review Registration: https://doi.org/10.37766/inplasy2021.9.0009, identifier: INPLASY20211900.
Introduction
Halitosis, or bad breath, is a term referring to an unpleasant or annoying odor that emanates from the oral cavity of an individual and affects between 30 and 50% of the population (1). Its main cause is the putrefaction of sulfur-containing amino acids, with hydrogen sulfide, methylmercaptan, and dimethylsulfide being the main culprits (2). Occasional halitosis may be associated with the consumption of certain condiments or food seasonings, such as onion or garlic, or with certain pathologies such as uremia or diabetes (3, 4).
The International Society for Breath Odor Research (ISBOR) classifies halitosis according to its origin into three categories: genuine halitosis, pseudohalitosis, and halitophobia. Genuine halitosis can occur under certain pathological conditions, or in a physiological form, in which the malodor originates in the oral cavity and is not associated with a specific pathological condition or disease. This type of halitosis exhibits a bad breath odor that exceeds the socially acceptable level, produced by putrefaction processes in the oral cavity, without the existence of a specific disease or pathological condition that causes it, being its main origin, the plaque (biofilm) accumulated in the interdental spaces, the dorsoposterior region of the tongue, under the prosthesis or in the orthodontic appliances (5, 6).
Halitosis has a great psychological impact due to the social isolation it produces, being one of the conditions for which people seek dental care, after caries and periodontal disease (7, 8). However, it should be noted that people with chronic halitosis minimize contact with their social environment, resulting in a low quality of life and decreased self-esteem, precisely because of the social difficulties in relating to others, even avoiding intimacy, leading to the search for medical help, precisely because of the social consequences that their condition entails (7, 9).
Probiotics are non-pathogenic live microorganisms, which are administered to improve microbial balance, especially in the gastrointestinal tract (10). They consist of yeasts or lactic acid bacteria, such as Lactobacillus species, and are regulated as dietary supplements and foods. They exert their beneficial effects through several mechanisms, such as reduction of intestinal pH, reduction of bacterial colonization and invasion of pathogenic organisms, along with modification of the host immune response (11). The most commonly used are lactic acid bacteria, specifically Lactobacillus and Bifidobacterium species (12). In general, they are used for the prevention and treatment of various medical conditions and to support general well-being.
In recent years, certain studies have proposed them to control plaque formation and prevent the breakdown of microbial homeostasis, acting on the maintenance and improvement of oral health (13–16). Figure 1 presents a graph demonstrating the increase in publications over the last 20 years (prepared using data from the US National Library of Medicine) (17).
Figure 1. Publications in the US National Library of Medicine database with the following keywords: “Halitosis” and “Oral Health.” Source: US National Library of Medicine (17).
The objective of this systematic review with meta-analysis was to evaluate the efficacy of probiotics in genuine halitosis of oral origin.
Materials and Methods
Study Design
A bibliographic search was conducted following the PRISMA [Preferred Reporting Items for Systemic Reviews and Meta-Analyses http://www.prisma-statement.org (accessed on 5 June, 2021)] guidelines for systematic reviews and meta-analyses INSPLAY registration number: INPLASY202190009. The review also fulfilled the PRISMA 2015 Checklist (18) (Supplementary Table 1).
Question of Interest
The PICO (population, intervention, comparison, and outcome) question was “Are probiotics effective for the reduction or elimination of oral halitosis?” with the following components: population-subjects suffering from halitosis; intervention-probiotic administration; control-subjects not receiving probiotics; outcome-reduction of halitosis.
Data Sources and Search Strategy
The PubMed, EMBASE and Web of Science (WOS) electronic databases were searched for findings published, in the last 15 years until July 2021. The MeSH (Medical Subject Headings) terms used in the MEDLINE (PuBMed) databases were: “Probiotics” [MeSH terms], “Halitosis” [MeSH terms], “Mouth diseases” [MeSH terms], “Oral health” [MeSH terms], “Humans” [MeSH terms], “Randomized Clinical Trials” [MeSH terms]; the Boolean operator AND was used to refine the search. The search terms used in Embase were: “Probiotics,” “Halitosis,” “Randomized Clinical Trials.” In WOS, the search terms were: “Probiotics,” “Halitosis,” “Oral health,” “Randomized Clinical Trials”; the Boolean operators AND-OR were used to refine the search.
Inclusion and Exclusion Criteria
The inclusion criteria for the study selection were: Articles published in English; Randomized clinical studies referring to the benefits of probiotics on oral halitosis; Follow-up for at least 2 weeks.
The exclusion criteria for the study selection were: Animal studies; In vitro studies; Narrative and systematic reviews; Studies on the benefits of probiotics in other types of oral pathologies; Clinical cases duplicate and informative studies, in languages other than English or with a follow-up of <2 weeks.
Data Extraction and Analysis
Studies that did not address the research question were eliminated, and the titles and abstracts of the selected articles were collected and entered into an Excel spreadsheet. Two reviewers (NL-V and AL-V) independently selected the titles and abstracts. Disagreements about the inclusion of studies were resolved by discussion between the two reviewers. Subsequently, the full texts of the selected studies were obtained for review and inclusion. The bibliographic references of each study were also reviewed as possible sources for identifying additional studies.
Quality and Risk of Bias Assessments
The methodological quality and risk of bias of each eligible trial were independently assessed using the Cochrane Collaboration tool for assessing risk of bias in randomized trials by two investigators (19). Any discrepancies were resolved through discussion with a third investigator.
Statistical Analysis
The meta-analysis was performed using RevMan software [Review Manager (RevMan) (Computer program). Version 5.4.1, The Cochrane Collaboration, 2020]. Given the homogeneity of the studies, a fixed effects model was used; the mean difference (MD) and standard deviation (SD) were used to evaluate the continuous variable (probiotic) with a 95% confidence interval (CI).
Results
Characteristics of the Studies
Until July 2021, a total of 14 studies were identified and subsequently evaluated by the reviewers. After a first screening, three duplicate studies were eliminated. A second evaluation led to the elimination of seven studies, which were considered inappropriate because they did not clearly meet the inclusion criteria. Finally, four studies were selected that met the inclusion criteria in full (20–23) (Figure 2, Flowchart). A total of 283 participants were evaluated and the longest follow-up was 12 weeks (20, 21). Three of the studies (20–22) used Streptococcus salivarius (SS), strains K12 and M18, as a probiotic and one (23) used Weissella cibaria (WC). Three studies evaluated the Organoleptic Test (OLT) and Volatile Sulfur Compounds Levels (VSCLs) (20, 22, 23) and one (21), exclusively, the latter parameter. The study by Lee et al. (23) was the only one to measure the Bad Breath (BB) improvement scores. Tables 1, 2 provide a summary of the details of the RCTs.
Figure 2. Flowchart.
Table 1. General characteristics of studies.
Table 2. Patients and parameters measured in the included studies.
Quality and Risk of Bias
The methodological quality and risk of bias of each eligible study were evaluated using the Cochrane Collaboration tool for assessing the risk of bias, and the results are presented in Figure 3. All studies were randomized. All studies met the items Random sequence generation, Allocation concealment and Blinding of participants and staff; the item Selective reporting was the item with the least clear risk of bias. The study by Jamali et al. (20), showed the highest number of unclear items.
Figure 3. The Cochrane Collaboration's tool for assessing the risk of bias of included randomized controlled trials.
Meta-Analysis Results
All included studies measured the effect of different probiotics on genuine halitosis. A fixed-effects meta-analysis was performed, based on the results of four studies. The overall results showed homogeneity (I2 = 0%, CI 95%). The studies by Jamali et al. (20) and Lee et al. (23) had the highest weight in the meta-analysis; the study by He et al. (22), despite having a much lower weight than the other studies (9.8%) did not have a high risk of bias, so we did not consider it necessary to perform a sensitivity analysis.
No statistical significance was found between the intervention group and the control group (p = 0.53) (Figure 4).
Figure 4. Forest Plot of the effectiveness on halitosis of probiotic vs. placebo, in a fixed effects model. SD, Standard Deviation, CI, Confidence Interval.
Publication Bias and Heterogeneity
The RCTs included in the meta-analysis showed no graphic signs of publication bias, as can be seen in the Funnel Plot in Figure 5.
Figure 5. Funnel Plot of publication bias.
Discussion
Oral health is a vital component of public health. The World Health Organization defines it as a state free of chronic pain in the mouth and face, throat cancer, oral sores, birth defects such as cleft lip and palate, periodontal diseases, dental caries, tooth loss, and other diseases and disorders affecting the oral cavity (24). Halitosis of any kind is a public health problem, especially because of the social rejection it entails (7).
The term probiotic was first used in the 1960s (25). Since then, bacteriotherapy has led to alternative ways of fighting certain infectious diseases, with fewer side effects than conventional drugs. During the last few years, the use of probiotics has gained interest among the dental community, developing studies focused on the reduction of different pathologies of the oral cavity, such as the incidence of dental caries, periodontitis, halitosis, or infections such as oral candidiasis. The modulation of the microbiota through the use of probiotics or new generation beneficial microbes, constitutes a future perspective in the development of pharmaceutical tools to maintain health (26, 27), however, randomized clinical studies are scarce, most of them being reduced to reviews of the scientific literature.
Halitosis is mainly attributed to biofilm accumulation on the dorsum of the tongue, interdental spaces, under orthodontic and orthopedic prostheses and appliances, and chronic inflammatory diseases of the periodontium. Self-care products, such as chewing gums, mouth rinses and sprays, and toothpastes, can temporarily mask oral odor and improve the individual's satisfaction and self-esteem; however, the proper approach remains professional treatment and appropriate strategies for the reduction and/or elimination of the microorganism-producing causes (28, 29).
Although De Boever and Loesche (30) had suggested that the proteolytic microbiota colonizing the tongue, contributes greatly to halitosis by its action of degrading food proteins, and therefore a probiotic strain colonizing the tongue surface and not producing odorous metabolic by-products would be well-suited to control halitosis, it was Burton et al. who addressed the treatment of halitosis by probiotics (31, 32) in a study of 23 subjects subjected to chlorhexidine mouth rinses and the use of SS K12 tablets vs. placebo, demonstrating a significant reduction in halitosis levels. In the same aspect, Jamali et al. (20), highlighted the importance of pre-rinse with chlorhexidine before probiotic use.
Different probiotics have been used in the treatment of halitosis; two of the included studies included in our meta-analysis used SS K12 (20, 22). In fact, SS is known to be a pioneer colonizer of oral surfaces and predominant in the saliva of non-halitosis subjects (33), thus, it is considered to have excellent potential for use as a probiotic, targeting halitosis-producing bacteria. Masdea et al. in an in vitro study (34), demonstrated the antimicrobial activity of SS K12 against several bacteria responsible for halitosis, including Solobacterium moorei, which has been described as one of the main culprits of oral malodor.
The study by Lee et al. (23) used WC as a probiotic. This is a Gram-positive bacterium, widely represented in saliva or fermented foods, which exhibits preventive effects on the formation of biofilms and the production of volatile sulfur compounds, which would suggest its use as a probiotic in oral halitosis care (35–37).
Yoo et al. (38) and Meurman and Stamatova (39) studied in vitro the antimicrobial activity of SS strain M18 against the bacteria causing oral malodor; Benic et al. (21) in a randomized study on a sample of 32 patients with orthodontic appliances demonstrated the effectiveness of the oral probiotic SS M18, which reduced the level of halitosis, although it had minimal effects on the plaque index and dental biofilm microflora.
Similarly, we have to consider that bad breath can vary between children and adults, throughout the day, before and after menstruation in women, and at the time of starting to speak (40–42).
On the other hand, measurement systems can lead to confusing results. The studies included in this meta-analysis used different measurement systems; Jamali et al. (20) and Lee et al. (23) used the OLT using a judge examiner and the Greenman test (43), however, Benic et al. (21) and He et al. (22) used measuring devices, such as the Halimeter®, Interscan, USA (44).
The OLT is the simplest method of measuring oral malodor by “human judges” and reflects an everyday situation and despite being considered the gold standard for measuring bad breath, it is quite embarrassing for both (examiner and examinee). Both the reliability and reproducibility of this method are problematic. Concerning the agreement between “judges,” this can be improved by standardizing the sense of smell, using different odor solution kits (e.g., T&T Olfactometer®, Daiichi Yakuhin Sangyo, Tokyo, Japan). At the same time, for better inter-judge agreement, patients should refrain from oral hygiene practices, smoking, ingesting antibiotics and meals with garlic, onion, and spices before the measurement; moreover, inter-judge agreement increases if they themselves also avoid drinking coffee and tea, smoking, and using cosmetics with odor before the organoleptic tests (45).
Currently, given the development of new technologies that identify and measure the compounds present in the breath and the discomfort experienced by both (patient and health professional), OLT are increasingly out of use, with the use of monitors for measuring VSCLs, such as Halimeter®, which measures total volatile sulfur compounds, although it does not identify them, and therefore is not in itself a sufficient diagnostic method to evaluate the existence of halitosis, although it is the most reliable method, since it separates the gases by their molecular weight and allows their identification and measurement in samples of exhaled air, saliva, feces, etc. (46).
Gas chromatography can be combined with mass spectrometry, thus increasing the range of this method. It is considered a highly objective, reproducible, and reliable method. However, few clinics have this system implemented, due to its high cost, the need for highly qualified and trained professionals to handle it, and the long duration of its procedures (47). ISBOR (International Society for Breath Odor Research) is making an effort for the creation and maintenance of a database, which already includes more than 3,000 registered volatile compounds (48).
The present systematic review had several limitations. Firstly, the small number of studies included in the meta-analysis; secondly, some of the studies complemented the use of probiotics with the use of an antiseptic (chlorhexidine) (20), with the consequent bias in the results; third, another of the included studies was performed in patients with orthodontic appliances (21), with the consequent increase in bacterial plaque retention caused by this type of appliance; fourth, there were different follow-up periods in the studies (4, 8, and 12 weeks) and different parameters indicative of oral malodor were measured; fifth, different probiotics (SS K12, M18 and WC) were used. Therefore, the results obtained should be taken with caution.
Conclusions
The lack of statistical significance (p = 0.53) cannot point in a particular direction, as the term “statistically significant” does not mean having relevant effects, as a statistically significant association may not be clinically or epidemiologically relevant. Therefore, we believe that some probiotics appear to have a beneficial effect on halitosis of oral origin, however, multicenter clinical trials with sufficient statistical power and the use of high-throughput analytical tools are needed to establish real evidence of the role of probiotics in oral health and to justify their use in halitosis. At present, existing trials remain scarce.
Data Availability Statement
The original contributions presented in the study are included in the article/Supplementary Material, further inquiries can be directed to the corresponding author/s.
Author Contributions
NL-V and AL-V: conceptualization, writing, review, and editing. JA and BM: methodology. AL-V, CR, AS, and JA: validation. NL-V: formal analysis. NL-V and BM: data curation. AL-V: supervision. All authors have read and agreed to the published version of the manuscript.
Conflict of Interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Publisher's Note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Supplementary Material
The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fnut.2021.787908/full#supplementary-material
References
1. Miyazaki H, Sakao S, Katoh Y, Takehara T. Correlation between volatile sulphur compounds and certain oral health measurements in the general population. J Periodontol. (1995) 66:679–84. doi: 10.1902/jop.1995.66.8.679
2. Hampelska K, Jaworska MM, Babalska ZŁ, Karpiński TM. The role of oral microbiota in intra-oral halitosis. J Clin Med. (2020) 9:2484. doi: 10.3390/jcm9082484
3. Al-Zahrani MS, Zawawi KH, Austah ON, Al-Ghamdi HS. Self-reported halitosis in relation to glycated hemoglobin level in diabetic patients. Open Dent J. (2011) 5:54–157. doi: 10.2174/1874210601105010154
4. Porciani PF, Grandini S. Effect of green tea-added tablets on volatile sulfur-containing compounds in the oral cavity. J Clin Dent. (2016) 27:110–3.
5. Loesche WJ, Kazor C. Microbiology and treatment of halitosis. Periodontol 2000. (2002) 28:256–79. doi: 10.1034/j.1600-0757.2002.280111.x
6. Torsten M, Gómez-Moreno G, Aguilar-Salvatierra A. Drug-related oral malodour (halitosis): a literature review. Eur Rev Med Pharmacol Sci. (2017) 21:4930–4.
7. Kursun S, Acar B, Atakan C, Oztas B, Paksoy CS. Relationship between genuine and pseudohalitosis and social anxiety disorder. J Oral Rehabil. (2014) 41:822–8. doi: 10.1111/joor.12206
8. Rayman S, Almas K. Halitosis among racially diverse populations: an update. Int J Dent Hyg. (2008) 6:2–7. doi: 10.1111/j.1601-5037.2007.00274.x
9. McKeown L. Social relations and breath odour. Int J Dent Hyg. (2003) 1:213–7. doi: 10.1034/j.1601-5037.2003.00056.x
10. Senok AC, Ismaeel AY, Botta GA. Probiotics: facts and myths. Clin Microbiol Infect. (2005) 11:958–66. doi: 10.1111/j.1469-0691.2005.01228.x
12. Santosa S, Farnworth E, Jones PJ. Probiotics and their potential health claims. Nutr Rev. (2006) 64:265–74. doi: 10.1111/j.1753-4887.2006.tb00209.x
13. López-López A, Camelo-Castillo A, Ferrer MD, Simon-Soro Á, Mira A. Health- associated niche inhabitants as oral probiotics: the case of Streptococcus dentisani. Front Microbiol. (2017) 8:379. doi: 10.3389/fmicb.2017.00379
14. Rao Y, Lingamneni B, Reddy D. Probiotics in oral health—a review. J N J Dent Assoc. (2012) 83:28–32.
15. Flichy-Fernández AJ, Alegre-Domingo T, Peñarrocha-Oltra D, Peñarrocha-Diago M. Probiotic treatment in the oral cavity: an update. Med Oral Patol Oral Cir Bucal. (2010) 15:e677–680. doi: 10.4317/medoral.15.e677
17. US National Library of Medicine. Accelerating Biomedical Discovery and Data-Powered Health. (2020). Available online at: https://www.nlm.nih.gov (accessed June 20, 2021).
18. Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, Petticrew M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev. (2015) 4:1. doi: 10.1186/2046-4053-4-1
19. Higgins JP, Altman D, Gotzsche PC, Juni P, Moher D, Oxman AD, et al. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ. (2011) 343:1–9 doi: 10.1136/bmj.d5928
20. Jamali Z, Aminabadi NA, Samiei M, Sighari Deljavan A, Shokravi M, Shirazi S. Impact of chlorhexidine pretreatment followed by probiotic Streptococcus salivarius strain K12 on halitosis in children: a randomized controlled clinical trial. Oral Health Prev Dent. (2016) 14:305–13. doi: 10.3290/j.ohpd.a36521
21. Benic GZ, Farella M, Morgan XC, Viswam J, Heng NC, Cannon RD, et al. Oral probiotics reduce halitosis in patients wearing orthodontic braces: a randomized, triple-blind, placebo-controlled trial. J Breath Res. (2019) 13:036010. doi: 10.1088/1752-7163/ab1c81
22. He L, Yang H, Chen Z, Ouyang X. The effect of Streptococcus salivarius K12 on halitosis: a double-blind, randomized, placebo-controlled trial. Probiotics Antimicrob Proteins. (2020) 12:1321–9. doi: 10.1007/s12602-020-09646-7
23. Lee DS, Lee SA, Kim M, Nam SH, Kang MS. Reduction of halitosis by a tablet containing Weissella cibaria CMU: a randomized, double-blind, placebo-controlled study. J Med Food. (2020) 23:649–57. doi: 10.1089/jmf.2019.4603
24. World Health Organisation. Enfermedad por coronavirus (COVID-19). Available online at: https://www.who.int/es (accessed July 14, 2021).
25. Kistler JO, Pesaro M, Wade WG. Development and pyrosequencing analysis of an in-vitro oral biofilm model. BMC Microbiol. (2015) 15:24. doi: 10.1186/s12866-015-0364-1
26. Singh VP, Sharma J, Babu S, Rizwanulla, Singla A. Role of probiotics in health and disease: a review. J Pak Med Assoc. (2013) 63:253–7.
27. Mundula T, Ricci F, Barbetta B, Baccini M, Amedei A. Effect of probiotics on oral candidiasis: a systematic review and meta-analysis. Nutrients. (2019) 11:2449. doi: 10.3390/nu11102449
28. Yaegaki K, Coil JM. Examination, classification, and treatment of halitosis, clinical perspectives. J Can Dent Assoc. (2000) 66:257–61.
29. Akaji EA, Folaranmi N, Ashiwaju O. Halitosis: a review of the literature on its prevalence, impact and control. Oral Health Prev Dent. (2014) 12:297–304. doi: 10.3290/j.ohpd.a33135
30. De Boever EH, Loesche WJ. Assessing the contribution of anaerobic microflora of the tongue to oral malodor. J Am Dent Assoc. (1995) 126:1384–93. doi: 10.14219/jada.archive.1995.0049
31. Burton JP, Chilcott CN, Tagg JR. The rationale and potential for the reduction of oral malodour using Streptococcus salivarius probiotics. Oral Dis. (2005) 11:29–31. doi: 10.1111/j.1601-0825.2005.01084.x
32. Burton JP, Chilcott CN, Moore CJ, Speiser G, Tagg JR. A preliminary study of the effect of probiotic Streptococcus salivarius K12 on oral malodour parameters. J Appl Microbiol. (2006) 100:754–64. doi: 10.1111/j.1365-2672.2006.02837.x
33. Kazor CE, Mitchell PM, Lee AM, Stokes LN, Loesche WJ, Dewhirst FE, et al. Diversity of bacterial populations on the tongue dorsa of patients with halitosis and healthy patients. J Clin Microbiol. (2003) 41:558–63. doi: 10.1128/JCM.41.2.558-563.2003
34. Masdea L, Kulik EM, Hauser-Gerspach I, Ramseier AM, Filippi A, Waltimo T. Antimicrobial activity of Streptococcus salivarius K12 on bacteria involved in oral malodour. Arch Oral Biol. (2012) 57:1041–7. doi: 10.1016/j.archoralbio.2012.02.011
35. Jang HJ, Kang MS, Yi SH, Hong JY, Hong SP. Comparative study on the characteristics of Weissella cibaria cmu and probiotic strains for oral care. Molecules. (2016) 21:1752. doi: 10.3390/molecules21121752
36. Kang MS, Kim BG, Chung J, Lee HC, Oh JS. Inhibitory effect of Weissella cibaria isolates on the production of volatile sulphur compounds. J Clin Periodontol. (2006) 33:226–32. doi: 10.1111/j.1600-051X.2006.00893.x
37. Kang M-S, Chung J, Kim S-M, Yang K-H, Oh J-S. Effect of Weissella cibaria isolates on the formation of Streptococcus mutans biofilm. Caries Res. (2006) 40:418–25. doi: 10.1159/000094288
38. Yoo HJ, Jwa SK, Kim DH, Ji YJ. Inhibitory effect of Streptococcus salivarius K12 and M18 on halitosis in vitro. Clin Exp Dent Res. (2020) 6:207–14. doi: 10.1002/cre2.269
39. Meurman JH, Stamatova IV. Probiotics: evidence of oral health implications. Folia Med. (2018) 60:21–9. doi: 10.1515/folmed-2017-0080
40. Alqutami J, Elger W, Grafe N, Hiemisch A, Kiess W, Hirsch C. Dental health, halitosis and mouth breathing in 10-to-15-year-old children: a potential connection. Eur J Paediatr Dent. (2019) 20:274–9. doi: 10.23804/ejpd.2019.20.04.03
41. Shon HS, Kim KO, Jung JK, Cha EJ, Lee SO, Kim KA. Intra-oral factors influencing halitosis in young women. Osong Public Health Res Perspect. (2018) 9:340–7. doi: 10.24171/j.phrp.2018.9.6.08
42. Mento C, Lombardo C, Milazzo M, Whithorn NI, Boronat-Catalá M, Almiñana-Pastor PJ, et al. Adolescence, adulthood and self-perceived halitosis: a role of psychological factors. Medicina. (2021) 57:614. doi: 10.3390/medicina57060614
43. Scully C, Greenman J. Halitosis. Periodontology 2000. (2008) 48:66–75. doi: 10.1111/j.1600-0757.2008.00266.x
44. Sopapornamorn P, Ueno M, Vachirarojpisan T, Shinada K, Kawaguchi Y. Association between oral malodor and measurements obtained using a new sulfide monitor. J Dent. (2006) 34:770–4. doi: 10.1016/j.jdent.2006.02.004
45. Laleman I, Dekeyser C, Wylleman A, Teughels W, Quirynen M. The OralChromaTM CHM-2: a comparison with the OralChromaTM CHM-1. Clin Oral Investig. (2020) 24:2829–36. doi: 10.1007/s00784-019-03148-9
46. Evirgen S, Kamburoglu K. Effects of tongue coating and oral health on halitosis among dental students. Oral Health Prev Dent. (2013) 11:169–73. doi: 10.3290/j.ohpd.a29361
47. Xu Y, Yu Z, Chen X, Zhou Y, Zhou K, Zhang Z, et al. Rapid and accurate determination of trace volatile sulfur compounds in human halitosis by an adaptable active sampling system coupling with gas chromatography. J Sep Sci. (2020) 43:1830–7. doi: 10.1002/jssc.201901191
Keywords: probiotics, halitosis, oral malodor, bad breath, oral health, randomized clinical trial
Citation: López-Valverde N, López-Valverde A, Macedo de Sousa B, Rodríguez C, Suárez A and Aragoneses JM (2022) Role of Probiotics in Halitosis of Oral Origin: A Systematic Review and Meta-Analysis of Randomized Clinical Studies. Front. Nutr. 8:787908. doi: 10.3389/fnut.2021.787908
Received: 12 November 2021; Accepted: 30 December 2021;
Published: 21 January 2022.
Edited by:
Javier Carballo, University of Vigo, SpainReviewed by:
Luigi Santacroce, University of Bari Aldo Moro, ItalyCrispin Celis, Pontificia Universidad Javeriana, Colombia
Copyright © 2022 López-Valverde, López-Valverde, Macedo de Sousa, Rodríguez, Suárez and Aragoneses. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Ana Suárez, ana.suarez@universidadeuropea.es